Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc.TYRA · filed Nov 17, 2025
- Accession no.
- 0001193125-25-284935
- Filed
- Nov 17, 2025
- Trade date
- Nov 13-17, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $2.11M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Common Stock | SSaleDisposed | −1,111 | $16.00F2 | −$17,776 | 426,870 | Direct | |
| Nov 14, 2025 | Common Stock | SSaleDisposed | −110,228 | $16.02F3 | −$1,765,852.56 | 316,642 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −18,572 | $16.11F4 | −$299,194.92 | 298,070 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −1,500 | $17.07F5 | −$25,605 | 296,570 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.02. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.13. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $17.00. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.06 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.